Compass Therapeutics Stock News & Updates

[WKN: A2QF3P | Symbol: CMPX]

Compass Therapeutics: Canaccord Recommends Buy with Nearly 90% Price Potential!

Compass Therapeutics (CMPX) is a biotech company focused on developing innovative immunotherapies against...

Compass Therapeutics: H.C. Wainwright Praises the Phase 2/3 Topline Results of Tovecimig - Expert Sees 627% Price Potential!

The pipeline of Compass Therapeutics (CMPX) is the main driver of investor interest. The company has...

Analysts' Top 5 Price Targets of August 12, 2025

Sartorius Vz . [DE0007165631] Jefferies upgrades from Hold to Buy and raises the price target...

  • 1